Variation in the apolipoprotein E gene (APOE) has been reported to be associated with longevity in humans. The authors assessed the allelic distribution of APOE isoforms ε2, ε3, and ε4 among 10,623 participants from 15 case-control and cohort studies of age-related macular degeneration (AMD) in populations of European ancestry (study dates ranged from 1990 to 2009). The authors included only the 10,623 control subjects from these studies who were classified as having no evidence of AMD, since variation within the APOE gene has previously been associated with AMD. In an analysis stratified by study center, gender, and smoking status, there was a decreasing frequency of the APOE ε4 isoform with increasing age (χ2for trend = 14.9 (1 df); P = 0.0001), with a concomitant increase in the ε3 isoform (χ2for trend = 11.3 (1 df); P = 0.001). The association with age was strongest in ε4 homozygotes; the frequency of ε4 homozygosity decreased from 2.7% for participants aged 60 years or less to 0.8% for those over age 85 years, while the proportion of participants with the ε3/ε4 genotype decreased from 26.8% to 17.5% across the same age range. Gender had no significant effect on the isoform frequencies. This study provides strong support for an association of the APOE gene with human longevity.

Additional Metadata
Keywords aged, apolipoprotein E2, apolipoprotein E3, apolipoprotein E4, apolipoproteins E, longevity, meta-analysis, multicenter study
Persistent URL dx.doi.org/10.1093/aje/kwr015, hdl.handle.net/1765/33396
Note Free full text at PubMed
Citation
McKay, G.J, Silvestri, G, Chakravarthy, U, Dasari, S, Fritsche, L.G, Weber, B.H.F, … Weeks, D.E. (2011). Variations in apolipoprotein e frequency with age in a pooled analysis of a large group of older people. American Journal of Epidemiology, 173(12), 1357–1364. doi:10.1093/aje/kwr015